Results 1 to 10 of about 1,148,241 (177)
An empirical analysis of primary and secondary pharmaceutical patents in Chile. [PDF]
PLoS ONE, 2015 We analyze the patent filing strategies of foreign pharmaceutical companies in Chile distinguishing between "primary" (active ingredient) and "secondary" patents (patents on modified compounds, formulations, dosages, particular medical uses, etc.). There
María José Abud +2 more
doaj +3 more sources
Polymorphs and prodrugs and salts (oh my!): an empirical analysis of "secondary" pharmaceutical patents. [PDF]
PLoS ONE, 2012 BACKGROUND: While there has been much discussion by policymakers and stakeholders about the effects of "secondary patents" on the pharmaceutical industry, there is no empirical evidence on their prevalence or determinants. Characterizing the landscape of
Amy Kapczynski, Chan Park, Bhaven Sampat
doaj +3 more sources
Perverse Results from Pharmaceutical Patents in the United States. [PDF]
IIC Int Rev Ind Prop Copyr Law, 2021 In the United States, pharmaceutical patents have had a number of perverse and anticompetitive effects on the development and marketing of prescription drugs.
Grimes W.
europepmc +2 more sources
In Defense of Secondary Pharmaceutical Patents in Drug Discovery and Development. [PDF]
ACS Med Chem Lett, 2020 "An important objective of modern pharmaceutical research is the discovery of new medical uses for known molecules" (UKSC 2018), a component of secondary pharmaceuticals.
Agranat I, Marom H.
europepmc +2 more sources
Globalization and Health, 2018 Background Despite the significant impact of pharmaceutical innovations on healthcare, our understanding is still limited because previous studies explored only a few cases and largely came from a linear perspective.
Qiaolei Jiang, Chunjuan Luan
doaj +2 more sources
Pharmaceutical Patents and Economic Inequality [PDF]
Health and Human Rights, 2023 Thomas Pogge
doaj +1 more source
Patent-Based Technological Overview of Propolis–Cyclodextrin Inclusion Complexes with Pharmaceutical Potential [PDF]
PharmaceuticsBackground/objectives: Propolis, known for its medicinal properties, faces challenges in pharmaceutical applications due to its low aqueous solubility, attributed to its resinous and hydrophobic nature.
Salvana Costa +10 more
doaj +2 more sources
(De-)assetizing pharmaceutical patents: Patent contestations behind a blockbuster drug
Economy and Society, 2021 Recent debates in public health and social sciences have shown how biofinancialization has been fuelled by patents’ transformation into ‘patent-as-assets’.
T. Bourgeron, Susi Geiger
semanticscholar +1 more source
A Review on the Indian Patent System and Its Implication on the Pharmaceutical Industry
Journal of Health Science and Medical Research (JHSMR), 2023 A patent is the main design of Intellectual Property Rights employed in the pharmaceutical industry. Claims of patents in India are imposed under the Patents Act of 1970.
Deepak Kumar Dash +2 more
doaj +1 more source
Journal of Economic Behavior & Organization, 2023 The role of the patent system in the pharmaceutical sector is highly debated also due to its strong public health implications. In this paper we develop an evolutionary, agent-based model of the pharmaceutical industry to explore the impact of different ...
G. Dosi +3 more
semanticscholar +1 more source